SFX by Ex Libris Inc.

Title:	Elevated Levels of Asymmetric Dimethylarginine in Chronic Heart Failure: A Pathophysiologic Link Between Oxygen Radical Load and Impaired Vasodilator Capacity and the Therapeutic Effect of Allopurinol
Source:	Clinical Pharmacology & Therapeutics [0009-9236] von Haehling, S yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bongartz, Lennart G G. "The severe cardiorenal syndrome: 'Guyton revisited'." European Heart Journal 26.1 (2004): 11-7.
description	2.	Webb, Amrita J. "Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase." Circulation research 103.9 (2008): 957-64.
description	3.	Ayalasomayajula, S. "A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects." Current medical research and opinion 24.3 (2008): 717-726.
description	4.	Costanzo, Maria Rosa R. "The cardiorenal syndrome: do we need a change of strategy or a change of tactics?" Journal of the American College of Cardiology 53.7 (2009): 597-9.
description	5.	Mahapatra, Himanshu S. "Cardiorenal syndrome." Iranian Journal of Kidney Diseases 3.2 (2009): 61-70.
description	6.	van der Putten, K. "The cardiorenal syndrome a classification into 4 groups?" Journal of the American College of Cardiology 53.15 (2009): 1340-1.
description	7.	"Combination treatment with ipragliflozin (ASP1941) and metformin in type 2 diabetes patients: a safety, pharmacokinetic and pharmacodynamic interaction study." Diabetologia 54.
description	8.	Aboud, Z. "The enterosalivary bioconversion of nitrate to nitrite underlies the blood pressure (BP) lowering and anti-platelet effects of a dietary nitrate load." British journal of clinical pharmacology 65.6 (2008): 999-999.
description	9.	Robertson, Sarah M. "Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects." Journal of acquired immune deficiency syndromes 49.5 (2008): 513-519.
description	10.	Ni, B. "Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis." Microcirculation 15.3 (2008): 251-67.
description	11.	Hu, H. "Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding." Thrombosis Research 100.3 (2000): 161-166.
description	12.	Shi, W. "Regulation of tetrahydrobioterin synthesis and bioavailability in endothelial cells." Cell Biochemistry and Biophysics 41.3 (2004): 415-433.
description	13.	House, C. "Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong." Intensive care medicine 34.5 (2008): 957-62.
description	14.	Hanafy, A. "Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug." Advanced Drug Delivery Reviews 59.6 (2007): 419-426.
description	15.	Geisberg, C. "Addressing the challenges of cardiorenal syndrome." Cleveland Clinic journal of medicine 73.5 (2006): 485-91.
description	16.	Smith, Richard E T E. "Antihypertensive therapies." Nature reviews. Drug discovery 6.8 (2007): 597-8.
description	17.	Vanin, A F F. "Nitric oxide synthase reduces nitrite to NO under anoxia." Cellular and molecular life sciences 64.1 (2006): 96-103.
description	18.	Halevy, S. "Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel." Journal of the American Academy of Dermatology 58.1 (2007): 25-32.
description	19.	Ronco, C. "Cardiorenal syndrome." Journal of the American College of Cardiology 52.19 (2008): 1527-39.
description	20.	Abe, M. "Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice." Current drug metabolism 12.1 (2011): 57-69.